Literature DB >> 23838106

Most important outcomes research papers on hypertension.

Ruijun Chen, Kumar Dharmarajan, Vivek T Kulkarni, Natdanai Punnanithinont, Aakriti Gupta, Behnood Bikdeli, Purav S Mody, Isuru Ranasinghe.   

Abstract

The following are highlights from the new series, Circulation: Cardiovascular Quality and Outcomes Topic Review. This series will summarize the most important manuscripts, as selected by the Editor, which have published in the Circulation portfolio. The objective of this new series is to provide our readership with a timely, comprehensive selection of important papers that are relevant to the quality and outcomes, as well as general cardiology audience. The studies included in this article represent the most significant research related to hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23838106      PMCID: PMC8152105          DOI: 10.1161/CIRCOUTCOMES.113.000424

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  60 in total

1.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

2.  Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.

Authors:  Alberto Zanchetti; M Gene Bond; Michael Hennig; Albrecht Neiss; Giuseppe Mancia; Cesare Dal Palù; Lennart Hansson; Bruno Magnani; Karl-Heinz Rahn; John L Reid; Josè Rodicio; Michel Safar; Lothar Eckes; Paolo Rizzini
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

3.  Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).

Authors:  Giuseppe Mancia; Helmut Schumacher; Josep Redon; Paolo Verdecchia; Roland Schmieder; Garry Jennings; Khalid Yusoff; Lars Ryden; G Lisheng Liu; Koon Teo; Peter Sleight; Salim Yusuf
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Jeanne Darbinian; Alan S Go; Carlos Iribarren
Journal:  Arch Intern Med       Date:  2005-04-25

6.  Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository.

Authors:  Ross D Fletcher; Richard L Amdur; Robert Kolodner; Chris McManus; Ronald Jones; Charles Faselis; Peter Kokkinos; Steven Singh; Vasilios Papademetriou
Journal:  Circulation       Date:  2012-04-19       Impact factor: 29.690

Review 7.  Dietary protein and blood pressure: a systematic review.

Authors:  Wieke Altorf-van der Kuil; Mariëlle F Engberink; Elizabeth J Brink; Marleen A van Baak; Stephan J L Bakker; Gerjan Navis; Pieter van 't Veer; Johanna M Geleijnse
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

8.  Elevated blood pressure in pregnancy and subsequent chronic disease risk.

Authors:  Tuija Männistö; Pauline Mendola; Marja Vääräsmäki; Marjo-Riitta Järvelin; Anna-Liisa Hartikainen; Anneli Pouta; Eila Suvanto
Journal:  Circulation       Date:  2013-02-12       Impact factor: 29.690

9.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Authors:  M R Law; N J Wald; J K Morris; R E Jordan
Journal:  BMJ       Date:  2003-06-28

10.  Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.

Authors:  Elisabeth B Magnussen; Lars J Vatten; George Davey Smith; Pål R Romundstad
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

View more
  2 in total

1.  Animal models for the study of primary and secondary hypertension in humans.

Authors:  Hiu Yu Lin; Yee Ting Lee; Yin Wah Chan; Gary Tse
Journal:  Biomed Rep       Date:  2016-10-18

Review 2.  Inositol 1,4,5-Trisphosphate Receptors in Hypertension.

Authors:  Ali H Eid; Ahmed F El-Yazbi; Fouad Zouein; Abdelilah Arredouani; Allal Ouhtit; Md M Rahman; Hatem Zayed; Gianfranco Pintus; Haissam Abou-Saleh
Journal:  Front Physiol       Date:  2018-07-26       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.